NL7510535A - Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten. - Google Patents

Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.

Info

Publication number
NL7510535A
NL7510535A NL7510535A NL7510535A NL7510535A NL 7510535 A NL7510535 A NL 7510535A NL 7510535 A NL7510535 A NL 7510535A NL 7510535 A NL7510535 A NL 7510535A NL 7510535 A NL7510535 A NL 7510535A
Authority
NL
Netherlands
Prior art keywords
preparation
arylpiperiines
new
pharmaceutical preparations
preparations
Prior art date
Application number
NL7510535A
Other languages
English (en)
Dutch (nl)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NL7510535A publication Critical patent/NL7510535A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
NL7510535A 1974-09-06 1975-09-05 Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten. NL7510535A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06

Publications (1)

Publication Number Publication Date
NL7510535A true NL7510535A (nl) 1976-03-09

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7510535A NL7510535A (nl) 1974-09-06 1975-09-05 Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.

Country Status (27)

Country Link
US (1) US4081450A (fr)
JP (3) JPS5929588B2 (fr)
AR (1) AR206937A1 (fr)
AT (1) AT350567B (fr)
BE (1) BE833044A (fr)
BG (2) BG24950A3 (fr)
CA (1) CA1069901A (fr)
CH (1) CH625787A5 (fr)
CS (1) CS188237B2 (fr)
DD (1) DD121636A5 (fr)
DE (1) DE2539452A1 (fr)
DK (1) DK153397C (fr)
ES (1) ES440771A1 (fr)
FR (2) FR2283679A1 (fr)
GB (1) GB1525584A (fr)
HU (1) HU173057B (fr)
IE (1) IE41610B1 (fr)
IL (1) IL48003A (fr)
NL (1) NL7510535A (fr)
NZ (1) NZ178501A (fr)
PH (2) PH12618A (fr)
PL (3) PL117501B1 (fr)
RO (1) RO68142A (fr)
SE (1) SE425489B (fr)
SU (2) SU629875A3 (fr)
YU (2) YU221675A (fr)
ZA (1) ZA755614B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
IL86061A (en) * 1987-04-16 1992-07-15 Lilly Co Eli Derivatives of trans-3,4-isomer of 4-methyl-4-phenyl-piperidines,process for their preparation and pharmaceutical compositions containing them
EP0299549A3 (fr) * 1987-07-09 1989-02-08 Duphar International Research B.V 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
ZA9610741B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
AU2014292799B2 (en) * 2013-07-15 2017-03-30 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD87036A (fr) *
US2892842A (en) * 1959-06-30 Their preparation
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
SE7509640L (sv) 1976-03-08
IL48003A0 (en) 1975-11-25
PL117501B1 (en) 1981-08-31
DK153397B (da) 1988-07-11
CH625787A5 (fr) 1981-10-15
JPS5916875A (ja) 1984-01-28
AT350567B (de) 1979-06-11
SE425489B (sv) 1982-10-04
GB1525584A (en) 1978-09-20
FR2299337A1 (fr) 1976-08-27
HU173057B (hu) 1979-02-28
JPS6012350B2 (ja) 1985-04-01
DK153397C (da) 1988-12-05
PH12618A (en) 1979-07-05
US4081450A (en) 1978-03-28
ATA685275A (de) 1978-11-15
JPS6026782B2 (ja) 1985-06-25
IL48003A (en) 1981-01-30
AU8431375A (en) 1977-03-03
SU621316A3 (ru) 1978-08-25
ES440771A1 (es) 1977-04-01
CA1069901A (fr) 1980-01-15
YU221675A (en) 1982-02-28
BE833044A (fr) 1976-03-03
FR2299337B1 (fr) 1979-01-19
JPS5148670A (fr) 1976-04-26
NZ178501A (en) 1978-09-20
AR206937A1 (es) 1976-08-31
PL108465B1 (en) 1980-04-30
IE41610B1 (en) 1980-02-13
PL100438B1 (pl) 1978-10-31
BG24950A3 (en) 1978-06-15
BG24802A3 (en) 1978-05-12
DD121636A5 (fr) 1976-08-12
JPS5929588B2 (ja) 1984-07-21
CS188237B2 (en) 1979-02-28
ZA755614B (en) 1977-04-27
PH14016A (en) 1980-12-08
SU629875A3 (ru) 1978-10-25
DE2539452A1 (de) 1976-03-18
FR2283679B1 (fr) 1979-09-14
FR2283679A1 (fr) 1976-04-02
YU233681A (en) 1982-02-28
IE41610L (en) 1976-03-06
DK397575A (da) 1976-03-07
RO68142A (fr) 1981-08-30
JPS6051174A (ja) 1985-03-22

Similar Documents

Publication Publication Date Title
NL7514811A (nl) Werkwijze ter bereiding van nieuwe thiazolylaceet- amidoverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede gevormde far- maceutische preparaten.
NL7510535A (nl) Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7503696A (nl) Werkwijze ter vervaardiging van farmaceutische preparaten, alsmede de aldus gevormde voort- brengselen.
NL7411047A (nl) Werkwijze ter bereiding van nieuwe pyrimidinen en van farmaceutische preparaten, die dergelij- ke pyrimidinen bevatten.
NL7506584A (nl) Werkwijze ter bereiding van farmaceutische prepa- raten en werkwijze ter bereiding van nieuwe ergo- linederivaten.
NL7501542A (nl) Werkwijze ter bereiding van nieuwe preparaten.
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
NL7415174A (nl) Werkwijze ter bereiding van nieuwe verbindingen, werkwijze ter vervaardiging van farmaceutische preparaten hiermede, alsmede de aldus gevormde voortbrengselen.
NL7503055A (nl) Werkwijze ter bereiding van therapeutische preparaten.
NL7506587A (nl) Werkwijze ter bereiding van nieuwe decahydroisochi- nolinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7606612A (nl) Werkwijze ter bereiding van nieuwe farmaceutische preparaten.
NL7503885A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe cefalosporineverbindingen.
NL7506588A (nl) Werkwijze ter bereiding van nieuwe decahydroisochi- nolineverbindingen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7416851A (nl) Werkwijze ter bereiding van nieuwe ethynverbin- dingen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7505140A (nl) Werkwijze ter bereiding van morfolinederivaten, werkwijze ter vervaardiging van farmaceutische preparaten hiermede, alsmede de aldus gevormde voortbrengselen.
NL7509053A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten en werkwijze ter bereiding van nieuwe cefalosporineverbindingen.
NL7514177A (nl) Werkwijze ter bereiding van nieuwe ergolinederi- vaten, alsmede werkwijze ter bereiding van farma- ceutische preparaten die deze ergolinederivaten bevatten.
NL7601411A (nl) Werkwijze ter bereiding van nieuwe o-aminooxi- men, alsmede werkwijze ter bereiding van far- maceutische preparaten en aldus verkregen ge- vormde farmaceutische preparaten.
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7514113A (nl) Werkwijze ter bereiding van farmaceutische prepa- raten, gevormde farmaceutische preparaten, alsme- de werkwijze ter bereiding van nieuwe cefemverbin- dingen.
NL7506011A (nl) Werkwijze ter bereiding van nieuwe derivaten van benzodiazepinen en van farmaceutische preparaten, die deze nieuwe derivaten bevatten.
NL7514429A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten en werkwijze ter bereiding van nieuwe cefemverbindingen.
NL7511341A (nl) Werkwijze ter bereiding van nieuwe stikstofhou- dende polycyclische verbindingen, werkwijze ter vervaardiging van farmaceutische preparaten hier- mede, alsmede de aldus gevormde voortbrengselen.
NL7605032A (nl) Werkwijze ter bereiding van nieuwe cefemverbindingen en werkwijze ter bereiding van farmaceutische pre- paraten.
NL7606043A (nl) Werkwijze ter bereiding van farmaceutische pre- paraten, alsmede werkwijze ter bereiding van nieuwe aminederivaten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BN A decision not to publish the application has become irrevocable